Stay updated on Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page.

Latest updates to the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe page now displays a new site revision tag (v3.6.3) replacing the previous v3.6.2, indicating a software update. This is a metadata-level change rather than a substantive update to study information or layout.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision metadata on the page was updated to v3.6.2, replacing the previous v3.6.0.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAn explicit recruitment status message ('No longer looking for participants') was added, signaling that the study is no longer enrolling. Additional navigation/help items ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') and a version update (Revision: v3.6.0) were introduced, with a formatting adjustment to the Intervention/Treatment heading.SummaryDifference0.5%

- Check34 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5. This indicates a new deployment or minor update to the page.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, signaling a new page version. This update reflects maintenance rather than changes to the study information presented on the page.SummaryDifference0.1%

- Check77 days agoChange DetectedA revision/version label at the bottom of the page was updated from v3.5.2 to v3.5.3. This represents a change in the site’s release version rather than any modification to the clinical study details.SummaryDifference0.1%

Stay in the know with updates to Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page.